Cargando…

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease

Alzheimer’s disease (AD) is one of the most common progressive neurodegenerative diseases, accompanied by global alterations in metabolic profiles. In the past 10 years, over hundreds of metabolomics studies have been conducted to unravel metabolic changes in AD, which provides insight into the iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Zhao, Hu, Tian, Su, Shijie, Liu, Jinman, Ma, Yinzhong, Zhuo, Yue, Fang, Shuhuan, Wang, Qi, Mo, Zhizhun, Pan, Huafeng, Fang, Jiansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174950/ https://www.ncbi.nlm.nih.gov/pubmed/35694256 http://dx.doi.org/10.3389/fphar.2022.904857

Ejemplares similares

Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury
por: Mo, Zhizhun, et al.
Publicado: (2022)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)

Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
por: Wang, Yang-Yang, et al.
Publicado: (2021)

Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
por: Yu, Wei, et al.
Publicado: (2020)

Integrated transcriptomics and metabolomics analysis of the hippocampus reveals altered neuroinflammation, downregulated metabolism and synapse in sepsis-associated encephalopathy
por: Xu, Kejia, et al.
Publicado: (2022)

Editorial: Data mining and network-driven analysis: Drug discovery and mechanism exploration by targeting vascular dysfunction
por: Dai, Zhao, et al.
Publicado: (2022)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023)

Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022)

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
por: Wu, Qihui, et al.
Publicado: (2020)

Integrative proteomics and metabolomics approach to identify the key roles of icariin-mediated protective effects against cyclophosphamide-induced spermatogenesis dysfunction in mice
por: Fang, Chunyan, et al.
Publicado: (2022)

Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer’s disease
por: Wang, Fu, et al.
Publicado: (2022)

Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
por: Dong, Qin, et al.
Publicado: (2015)

Therapeutic effect and mechanism of Anemarrhenae Rhizoma on Alzheimer’s disease based on multi-platform metabolomics analyses
por: Wang, Hui, et al.
Publicado: (2022)

Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin
por: Qi, Yan-Shuang, et al.
Publicado: (2022)

Identification of key pharmacodynamic markers of American ginseng against heart failure based on metabolomics and zebrafish model
por: Dong, Rong, et al.
Publicado: (2022)

β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
por: Sun, Xiaojuan, et al.
Publicado: (2015)

Urine Metabolomics Study on Potential Hepatoxic Biomarkers Identification in Rats Induced by Aurantio-Obtusin
por: Xu, Longlong, et al.
Publicado: (2020)

Toxicity of Tetradium ruticarpum: Subacute Toxicity Assessment and Metabolomic Identification of Relevant Biomarkers
por: Shan, Qiyuan, et al.
Publicado: (2022)

Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders
por: Fang, Jiansong, et al.
Publicado: (2017)

Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer’s Disease From the Perspective of Pathophysiological Processes
por: Zeng, Peng, et al.
Publicado: (2021)

In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L
por: Cai, Chuipu, et al.
Publicado: (2021)

Identification of Key Biomarkers and Immune Infiltration in Sciatic Nerve of Diabetic Neuropathy BKS-db/db Mice by Bioinformatics Analysis
por: Lin, Yixuan, et al.
Publicado: (2021)

In Silico Identification and Mechanism Exploration of Active Ingredients against Stroke from An-Gong-Niu-Huang-Wan (AGNHW) Formula
por: Song, Lei, et al.
Publicado: (2022)

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii
por: Han, Mei-Ling, et al.
Publicado: (2019)

Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer
por: Ruan, Xujun, et al.
Publicado: (2022)

The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer’s Disease
por: Cai, Haobin, et al.
Publicado: (2018)

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
por: Jiang, Huafeng, et al.
Publicado: (2023)

Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma
por: Pan, Yan, et al.
Publicado: (2022)

Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice
por: Zhou, Shengnan, et al.
Publicado: (2023)

Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
por: Duan, Yanfen, et al.
Publicado: (2021)

Metabolomic profiling combined with network analysis of serum pharmacochemistry to reveal the therapeutic mechanism of Ardisiae Japonicae Herba against acute lung injury
por: Han, Xiao-Xiao, et al.
Publicado: (2023)

A Comprehensive Analysis of Metabolomics and Transcriptomics Reveals Novel Biomarkers and Mechanistic Insights on Lorlatinib Crosses the Blood-Brain Barrier
por: Chen, Wei, et al.
Publicado: (2021)

Identification of Anti-HIV Biomarkers of Helichrysum Species by NMR-Based Metabolomic Analysis
por: Emamzadeh Yazdi, Simin, et al.
Publicado: (2022)

Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Tadalafil in Colorectal Cancer
por: Zhao, Pan, et al.
Publicado: (2022)

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
por: Bao, Shengnan, et al.
Publicado: (2020)

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
por: Yu, Wei, et al.
Publicado: (2022)

Emerging Applications of Metabolomics in Traditional Chinese Medicine Treating Hypertension: Biomarkers, Pathways and More
por: Yang, Mingxiao, et al.
Publicado: (2019)

Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics
por: Tu, Can, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_agfnc79k8ahcl1emppa3v8hnop